Heart Foundation alarmed over S3 PDE-5 inhibitors

The Heart Foundation is concerned about a bid to make erectile dysfunction drugs available over the counter.

The TGA is reviewing applications to give PDE-5 inhibitors sildenafil (including Viagra, Pfizer) and vardenafil (Levitra, Bayer) a Schedule 3 classification.

Heart Foundation Chief Medical Officer Professor Garry Jennings fears rescheduling will disrupt "the opportunity for doctors to